284 followers
RT @psychopharmacol: Paliperidone palmitate 3-month (175–525 mg) showed similar efficacy to PP1M (50–150 mg) in terms of relapse rates in E…
RT @psychopharmacol: Paliperidone palmitate 3-month (175–525 mg) showed similar efficacy to PP1M (50–150 mg) in terms of relapse rates in E…
RT @psychopharmacol: Paliperidone palmitate 3-month (175–525 mg) showed similar efficacy to PP1M (50–150 mg) in terms of relapse rates in E…
Paliperidone palmitate 3-month (175–525 mg) showed similar efficacy to PP1M (50–150 mg) in terms of relapse rates in Europeans patients with schizophrenia (PP3M: 7%; PP1M: 8%) and non-Europeans (PP3M: 9%; PP1M: 10%) during 48 weeks https://t.co/kr973RgXbH